Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5867 Articles

Jon C. Ogg | Jan 29, 2013 at 11:25 AM EST

Boston Scientific Turnaround Finally Begins to Take Shape

ThinkstockBoston Scientific Corp. (NYSE: BSX) is trading higher today after earnings and after a restructuring direction has been set. Unfortunately…

Jon C. Ogg | Jan 28, 2013 at 1:56 PM EST

Keryx Gets Back on the Map

ThinkstockKeryx Biopharmaceuticals Inc. (NASDAQ: KERX) has not been a household name in biotech investing, but the move on news on…

Paul Ausick | Jan 28, 2013 at 7:45 AM EST

Biogen Idec Results Mixed

ThinkstockBiogen Idec Inc. (NASDAQ: BIIB) reported fourth-quarter and full-year 2012 results before markets opened this morning. For the quarter, the…

Jon C. Ogg | Jan 25, 2013 at 10:22 AM EST

LipoScience IPO Prices Weak but Debuts Strong

ThinkstockLipoScience Inc. (NASDAQ: LPDX) is now open as a public company, now that its initial public offering has priced and…

Douglas A. McIntyre | Jan 23, 2013 at 6:27 AM EST

Americans Still Astonishingly Fat

ThinkstockIf current levels of obesity tell anything about current and future health care costs and the overall risks of disease…

Jon C. Ogg | Jan 22, 2013 at 1:21 PM EST

Arena Risk: Possible Drag on All Weight-Loss Drugs

ThinkstockArena Pharmaceuticals Inc. (NASDAQ: ARNA) is posing yet one more threat to ambitious biotechs and drug-makers who are targeting the…

Jon C. Ogg | Jan 18, 2013 at 9:50 AM EST

Analyst Calls Cancer Treatments Major Biotech Focus in 2013 (AMGN, GSK, ALXN, ARIA, CELG, INCY, ONXX)

ThinkstockThe dread and fear that can come with a cancer diagnosis have their roots in its killer nature. It is…

Jon C. Ogg | Jan 17, 2013 at 8:29 AM EST

Jefferies Top Global Pharmaceutical Stock Picks for 2013 (JEF, ABBV, NVS, SNY, PFE)

ThinkstockAfter a strong year of relative performance for pharmaceutical stocks in 2012, the analysts at Jefferies Group Inc. (NYSE: JEF)…

Paul Ausick | Jan 17, 2013 at 7:35 AM EST

UnitedHealth Earnings Good, but Not Exciting

ThinkstockUnitedHealth Group Inc. (NYSE: UNH) reported fourth-quarter and full-year 2012 results before markets opened this morning. The health insurance and…

Jon C. Ogg | Jan 16, 2013 at 8:16 AM EST

The Obesity Drug Stock Rally Has Started (OREX, ARNA, VVUS, BAC)

ThinkstockBack in December, we took an in-depth look at what has become a crowded race in the obesity drug market.…

Paul Ausick | Jan 15, 2013 at 7:44 AM EST

Forest Labs Sputters on Patent Expiration

ThinkstockForest Laboratories Inc. (NYSE: FRX) reported third-quarter fiscal 2013 results before markets opened this morning. The drug maker and marketer…

Paul Ausick | Jan 14, 2013 at 10:40 AM EST

Walmart Looking at Health Insurance Exchange

ThinkstockRetail behemoth Wal-Mart Stores Inc. (NYSE: WMT) is exploring the possibility of offering health insurance to small-business owners by setting…

Jon C. Ogg | Jan 14, 2013 at 10:04 AM EST

More Hope for Cancer Vaccines in 2013 (UBS, GSK, DNDN, AMGN)

ThinkstockCancer ranks on the list of global killers as number two. Over the years, great strides have been made not only…

Jon C. Ogg | Jan 14, 2013 at 9:09 AM EST

More Flu Season Stock Winners (HITK, PTX, PRGO)

ThinkstockThe 2012 to 2013 flu season has reached what is officially at pandemic levels. The government report last week showed…

Jon C. Ogg | Jan 11, 2013 at 2:16 PM EST

Can Dendreon’s Stock Really Double Again?

ThinkstockDendreon Corp. (NASDAQ: DNDN) is seeing shares surge higher on Friday on an analyst upgrade. The move higher is part…

1 … 308 309 310 311 312 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Boston Scientific Turnaround Finally Begins to Take Shape

Keryx Gets Back on the Map

Biogen Idec Results Mixed

LipoScience IPO Prices Weak but Debuts Strong

Americans Still Astonishingly Fat

Arena Risk: Possible Drag on All Weight-Loss Drugs

Analyst Calls Cancer Treatments Major Biotech Focus in 2013 (AMGN, GSK, ALXN, ARIA, CELG, INCY, ONXX)

Jefferies Top Global Pharmaceutical Stock Picks for 2013 (JEF, ABBV, NVS, SNY, PFE)

UnitedHealth Earnings Good, but Not Exciting

The Obesity Drug Stock Rally Has Started (OREX, ARNA, VVUS, BAC)

Forest Labs Sputters on Patent Expiration

Walmart Looking at Health Insurance Exchange

More Hope for Cancer Vaccines in 2013 (UBS, GSK, DNDN, AMGN)

More Flu Season Stock Winners (HITK, PTX, PRGO)

Can Dendreon’s Stock Really Double Again?

Social Security’s 2027 Raise Looks Like 3.8%. Here’s How Income Investors Give Themselves a Bigger One

Her Physical Therapist Said Medicare’s $2,480 Limit Had Been Reached. That Number Is Not a Coverage Cap.

Walmart (WMT) Stock Price Prediction: Where Our Price Target Sees the Stock Going Over the Next 12 Months

Her Physical Therapist Said Medicare’s $2,480 Limit Had Been Reached. That Number Is Not a Coverage Cap.

He "Retired" From Farming and Leased Out the Acres. Telling the Tenant What to Plant Kept Him Self-Employed.

Social Security’s 2027 Raise Looks Like 3.8%. Here’s How Income Investors Give Themselves a Bigger One

Her Physical Therapist Said Medicare’s $2,480 Limit Had Been Reached. That Number Is Not a Coverage Cap.

Health and Healthcare Articles

All Health and Healthcare Articles

Boston Scientific Turnaround Finally Begins to Take Shape

Keryx Gets Back on the Map

Biogen Idec Results Mixed

LipoScience IPO Prices Weak but Debuts Strong

Americans Still Astonishingly Fat

Arena Risk: Possible Drag on All Weight-Loss Drugs

Analyst Calls Cancer Treatments Major Biotech Focus in 2013 (AMGN, GSK, ALXN, ARIA, CELG, INCY, ONXX)

Jefferies Top Global Pharmaceutical Stock Picks for 2013 (JEF, ABBV, NVS, SNY, PFE)

UnitedHealth Earnings Good, but Not Exciting

The Obesity Drug Stock Rally Has Started (OREX, ARNA, VVUS, BAC)

Forest Labs Sputters on Patent Expiration

Walmart Looking at Health Insurance Exchange

More Hope for Cancer Vaccines in 2013 (UBS, GSK, DNDN, AMGN)

More Flu Season Stock Winners (HITK, PTX, PRGO)

Can Dendreon’s Stock Really Double Again?

Social Security’s 2027 Raise Looks Like 3.8%. Here’s How Income Investors Give Themselves a Bigger One

Her Physical Therapist Said Medicare’s $2,480 Limit Had Been Reached. That Number Is Not a Coverage Cap.

Walmart (WMT) Stock Price Prediction: Where Our Price Target Sees the Stock Going Over the Next 12 Months

Featured Reads

Her Physical Therapist Said Medicare’s $2,480 Limit Had Been Reached. That Number Is Not a Coverage Cap.

He "Retired" From Farming and Leased Out the Acres. Telling the Tenant What to Plant Kept Him Self-Employed.